{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:38:02Z","timestamp":1776443882387,"version":"3.51.2"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T00:00:00Z","timestamp":1355270400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0050850","type":"journal-article","created":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T22:10:45Z","timestamp":1355350245000},"page":"e50850","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Suppression of CB1 Cannabinoid Receptor by Lentivirus Mediated Small Interfering RNA Ameliorates Hepatic Fibrosis in Rats"],"prefix":"10.1371","volume":"7","author":[{"given":"Si-Wen","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben-Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-Xing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Bao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dao-Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,12,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"G709","DOI":"10.1152\/ajpgi.00451.2010","article-title":"Therapeutic targets in liver fibrosis","volume":"300","author":"JA Fallowfield","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1124\/jpet.111.188078","article-title":"Prevention of Fibrosis Progression in CCl4-Treated Rats: Role of the Hepatic Endocannabinoid and Apelin Systems","volume":"340","author":"V Reichenbach","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1476-5381.2011.01397.x","article-title":"The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings","volume":"163","author":"A Mallat","year":"2011","journal-title":"Br J Pharmacol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.dld.2010.08.010","article-title":"Recent advances in the understanding of the role of the endocannabinoid system in liver diseases","volume":"43","author":"L Huang","year":"2011","journal-title":"Dig Liver Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1478-3231.2009.01983.x","article-title":"Inhibition of hepatic tumour necrosis factor-alpha attenuates the anandamide-induced vasoconstrictive response in cirrhotic rat livers","volume":"29","author":"YY Yang","year":"2009","journal-title":"Liver Int"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/j.gastro.2009.01.004","article-title":"Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis","volume":"137","author":"M Domenicali","year":"2009","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.2174\/138161208785740063","article-title":"Endocannabinoids in liver disease and hepatic encephalopathy","volume":"14","author":"I Magen","year":"2008","journal-title":"Curr Pharm Des"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.phrs.2009.02.010","article-title":"The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation","volume":"60","author":"V Di Marzo","year":"2009","journal-title":"Pharmacol Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/hep.23779","article-title":"Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration","volume":"52","author":"F Teixeira-Clerc","year":"2010","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"19002","DOI":"10.1074\/jbc.M109.068460","article-title":"Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-gamma","volume":"285","author":"B Mukhopadhyay","year":"2010","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1073\/pnas.1017689108","article-title":"Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver","volume":"108","author":"B Mukhopadhyay","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"M Kano","year":"2009","journal-title":"Physiol Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/hep.21527","article-title":"CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis","volume":"45","author":"HE Wasmuth","year":"2007","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"30911","DOI":"10.1074\/jbc.272.49.30911","article-title":"The role of alpha1beta1 integrin in wound contraction. A quantitative analysis of liver myofibroblasts in vivo and in primary culture","volume":"272","author":"L Racine-Samson","year":"1997","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"22089","DOI":"10.1074\/jbc.M700998200","article-title":"Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro","volume":"282","author":"A Kaimori","year":"2007","journal-title":"J Biol Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/hep.23196","article-title":"Epithelial-to-mesenchymal transitions in the liver","volume":"50","author":"SS Choi","year":"2009","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/hep.24077","article-title":"Endocannabinoids in liver disease","volume":"53","author":"J Tam","year":"2011","journal-title":"Hepatology"},{"key":"ref18","article-title":"Transforming Growth Factor-\u03b21 Induced Epithelial-Mesenchymal Transition in Hepatic Fibrosis","volume":"59","author":"WR Bi","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"SL Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"R Derynck","year":"2003","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1073\/pnas.96.5.2345","article-title":"Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat","volume":"96","author":"Z Qi","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"12719","DOI":"10.1073\/pnas.96.22.12719","article-title":"In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: A potential new therapy for hepatic fibrosis","volume":"96","author":"J George","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"R Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/gut.2008.174904","article-title":"Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats","volume":"59","author":"HY Yue","year":"2010","journal-title":"Gut"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000101322","article-title":"Liver fibrosis: possible involvement of EMT","volume":"185","author":"T Ikegami","year":"2007","journal-title":"Cells Tissues Organs"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.21624","article-title":"Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis","volume":"45","author":"H Robertson","year":"2007","journal-title":"Hepatology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-0031-1272832","article-title":"Epithelial-mesenchymal interactions in biliary diseases","volume":"31","author":"L Fabris","year":"2011","journal-title":"Semin Liver Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2131","article-title":"Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype","volume":"7","author":"H Peinado","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"ref29","first-page":"1075","article-title":"Liver fibrosis: a dynamic and potentially reversible process","volume":"25","author":"D Povero","year":"2010","journal-title":"Histol Histopathol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-5926-6-7","article-title":"Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options","volume":"6","author":"OA Gressner","year":"2007","journal-title":"Comp Hepatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cmet.2007.12.007","article-title":"Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver","volume":"7","author":"WI Jeong","year":"2008","journal-title":"Cell Metab"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"23337","DOI":"10.1074\/jbc.M700194200","article-title":"Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition","volume":"282","author":"M Zeisberg","year":"2007","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/hep.23931","article-title":"E-Cadherin Antagonizes Transforming Growth Factor \u03b21 Gene Induction in Hepatic Stellate Cells by Inhibiting RhoA-Dependent Smad3 Phosphorylation","volume":"52","author":"IJ Cho","year":"2010","journal-title":"Hepatology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1096\/fj.06-7717com","article-title":"The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species","volume":"21","author":"SV Siegmund","year":"2007","journal-title":"FASEB J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1038\/cddis.2011.52","article-title":"Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis","volume":"2","author":"MP Lim","year":"2011","journal-title":"Cell Death Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1042\/CS20060260","article-title":"Effect of chronic CB1 cannabinoid receptor antagonism on livers of rats with biliary cirrhosis","volume":"112","author":"YY Yang","year":"2007","journal-title":"Clin Sci (Lond)"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0050850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T05:16:14Z","timestamp":1589001374000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0050850"}},"subtitle":[],"editor":[{"given":"Partha","family":"Mukhopadhyay","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,12]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0050850","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,12]]}}}